BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22966016)

  • 1. Functional, genetic, and epigenetic aspects of base and nucleotide excision repair in colorectal carcinomas.
    Slyskova J; Korenkova V; Collins AR; Prochazka P; Vodickova L; Svec J; Lipska L; Levy M; Schneiderova M; Liska V; Holubec L; Kumar R; Soucek P; Naccarati A; Vodicka P
    Clin Cancer Res; 2012 Nov; 18(21):5878-87. PubMed ID: 22966016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls.
    Slyskova J; Naccarati A; Pardini B; Polakova V; Vodickova L; Smerhovsky Z; Levy M; Lipska L; Liska V; Vodicka P
    Mutagenesis; 2012 Mar; 27(2):225-32. PubMed ID: 22294771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-individual variation in nucleotide excision repair pathway is modulated by non-synonymous polymorphisms in ERCC4 and MBD4 genes.
    Allione A; Guarrera S; Russo A; Ricceri F; Purohit R; Pagnani A; Rosa F; Polidoro S; Voglino F; Matullo G
    Mutat Res; 2013; 751-752():49-54. PubMed ID: 24004570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer.
    Mort R; Mo L; McEwan C; Melton DW
    Br J Cancer; 2003 Jul; 89(2):333-7. PubMed ID: 12865926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Base excision repair capacity as a determinant of prognosis and therapy response in colon cancer patients.
    Vodenkova S; Jiraskova K; Urbanova M; Kroupa M; Slyskova J; Schneiderova M; Levy M; Buchler T; Liska V; Vodickova L; Vymetalkova V; Collins A; Opattova A; Vodicka P
    DNA Repair (Amst); 2018 Dec; 72():77-85. PubMed ID: 30314738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.
    Kim KY; Han W; Noh DY; Kang D; Kwack K
    Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding.
    Pardini B; Rosa F; Barone E; Di Gaetano C; Slyskova J; Novotny J; Levy M; Garritano S; Vodickova L; Buchler T; Gemignani F; Landi S; Vodicka P; Naccarati A
    Clin Cancer Res; 2013 Nov; 19(21):6044-56. PubMed ID: 24036853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of blood storage conditions on DNA repair capacity measurements in peripheral blood mononuclear cells.
    Allione A; Porcedda P; Russo A; Ricceri F; Simonelli V; Minoprio A; Guarrera S; Pardini B; Mazzei F; Dogliotti E; Giachino C; Matullo G
    Mutat Res; 2013 Sep; 749(1-2):73-9. PubMed ID: 23727398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/β-catenin signaling pathway genes.
    Farkas SA; Vymetalkova V; Vodickova L; Vodicka P; Nilsson TK
    Epigenomics; 2014 Apr; 6(2):179-91. PubMed ID: 24811787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia provokes base excision repair changes and a repair-deficient, mutator phenotype in colorectal cancer cells.
    Chan N; Ali M; McCallum GP; Kumareswaran R; Koritzinsky M; Wouters BG; Wells PG; Gallinger S; Bristow RG
    Mol Cancer Res; 2014 Oct; 12(10):1407-15. PubMed ID: 25030372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas.
    Procopciuc LM; Osian G
    Chirurgia (Bucur); 2013; 108(5):711-8. PubMed ID: 24157118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
    Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
    Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage and nucleotide excision repair capacity in healthy individuals.
    Slyskova J; Naccarati A; Polakova V; Pardini B; Vodickova L; Stetina R; Schmuczerova J; Smerhovsky Z; Lipska L; Vodicka P
    Environ Mol Mutagen; 2011 Aug; 52(7):511-7. PubMed ID: 21520291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association selected polymorphisms of XRCC1, OGG1 and MUTYH gene and the level of efficiency oxidative DNA damage repair with a risk of colorectal cancer.
    Przybylowska K; Kabzinski J; Sygut A; Dziki L; Dziki A; Majsterek I
    Mutat Res; 2013; 745-746():6-15. PubMed ID: 23618615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency.
    Castells A; Payá A; Alenda C; Rodríguez-Moranta F; Agrelo R; Andreu M; Piñol V; Castellví-Bel S; Jover R; Llor X; Pons E; Elizalde JI; Bessa X; Alcedo J; Saló J; Medina E; Naranjo A; Esteller M; Piqué JM;
    Clin Cancer Res; 2006 Mar; 12(6):1686-92. PubMed ID: 16551850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-treatment recovery of suboptimal DNA repair capacity and gene expression levels in colorectal cancer patients.
    Slyskova J; Cordero F; Pardini B; Korenkova V; Vymetalkova V; Bielik L; Vodickova L; Pitule P; Liska V; Matejka VM; Levy M; Buchler T; Kubista M; Naccarati A; Vodicka P
    Mol Carcinog; 2015 Sep; 54(9):769-78. PubMed ID: 24585457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cross talk between pathways in the repair of 8-oxo-7,8-dihydroguanine in mouse and human cells.
    Parlanti E; D'Errico M; Degan P; Calcagnile A; Zijno A; van der Pluijm I; van der Horst GT; Biard DS; Dogliotti E
    Free Radic Biol Med; 2012 Dec; 53(11):2171-7. PubMed ID: 23010470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
    Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
    Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.